Id |
Subject |
Object |
Predicate |
Lexical cue |
T12 |
0-12 |
Sentence |
denotes |
Introduction |
T13 |
13-174 |
Sentence |
denotes |
The COVID-19 outbreak caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to endanger global health and to hamper the world economy. |
T14 |
175-239 |
Sentence |
denotes |
This outbreak started in December 2019 in Wuhan, Hubei Province. |
T15 |
240-330 |
Sentence |
denotes |
Unfortunately, currently, there is still no specific and effective treatment for COVID-19. |
T16 |
331-489 |
Sentence |
denotes |
Evidence shows that elderly people with SARS-CoV-2 infections and cardiovascular diseases, including hypertension, are at risk of developing severe cases [1]. |
T17 |
490-687 |
Sentence |
denotes |
A hypertension survey from 2012 to 2015 reported that 23.2% of Chinese people ≥18 years of age had hypertension, whereas the prevalence of hypertension was >55% among citizens ≥65 years of age [2]. |
T18 |
688-873 |
Sentence |
denotes |
RAS plays an important role in regulating electrolyte balance and blood pressure and comprises two pathways: the ACE/Ang II/AT1R pathway and the ACE2/Ang (1–7)/Mas receptor pathway [3]. |
T19 |
874-1091 |
Sentence |
denotes |
Under normal physiological conditions, the activity of the ACE/Ang II/AT1R axis and the ACE2/Ang (1–7)/Mas receptor axis are in a dynamic equilibrium state, maintaining the normal function of the corresponding system. |
T20 |
1092-1192 |
Sentence |
denotes |
Similar to SARS, SARS-CoV-2 is believed to invade the host through the cell entry receptor ACE2 [4]. |
T21 |
1193-1341 |
Sentence |
denotes |
SARS-CoV infections reduce ACE2 expression, resulting in an imbalance between the ACE/Ang II/AT1R axis and the ACE2/Ang (1–7)/Mas receptor axis [5]. |
T22 |
1342-1426 |
Sentence |
denotes |
Targeting the ACE/Ang II/AT1R axis is a novel therapeutic strategy for hypertension. |
T23 |
1427-1549 |
Sentence |
denotes |
ACEIs and ARAs not only inhibit the ACE/Ang II/AT1R pathway but also modulate the ACE2/Ang (1–7)/Mas receptor pathway [6]. |
T24 |
1550-1867 |
Sentence |
denotes |
The dysfunction of the renin-angiotensin system (RAS) has been observed in coronavirus infection disease (COVID-19) patients, but whether RAS inhibitors, such as angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II type 1 receptor blockers (ARBs), are associated with clinical outcomes remains unknown. |
T25 |
1868-1983 |
Sentence |
denotes |
Here, we aimed to evaluate the ability of RAS inhibitors to protect against COVID-19 in patients with hypertension. |